REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 3 filers reported holding REATA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $415,000 | -29.5% | 4,120 | -1.0% | 0.00% | -33.3% |
| Q2 2021 | $589,000 | +28.9% | 4,163 | -9.2% | 0.00% | +50.0% |
| Q1 2021 | $457,000 | -36.6% | 4,587 | -21.4% | 0.00% | -33.3% |
| Q4 2020 | $721,000 | +28.3% | 5,834 | +1.0% | 0.00% | 0.0% |
| Q3 2020 | $562,000 | -41.5% | 5,777 | -6.1% | 0.00% | -40.0% |
| Q2 2020 | $960,000 | +104.7% | 6,152 | +89.3% | 0.01% | +66.7% |
| Q1 2020 | $469,000 | -34.5% | 3,250 | -7.1% | 0.00% | 0.0% |
| Q4 2019 | $716,000 | +154.8% | 3,500 | 0.0% | 0.00% | +200.0% |
| Q3 2019 | $281,000 | -15.1% | 3,500 | -0.3% | 0.00% | -50.0% |
| Q2 2019 | $331,000 | +18.6% | 3,509 | +7.7% | 0.00% | +100.0% |
| Q1 2019 | $279,000 | +36.8% | 3,259 | +30.4% | 0.00% | 0.0% |
| Q3 2018 | $204,000 | – | 2,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 2,896,901 | $291,457,000 | 32.14% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 46,646 | $4,693,000 | 5.31% |
| Ikarian Capital, LLC | 471,400 | $47,423,000 | 3.34% |
| Duquesne Family Office | 695,033 | $69,927,000 | 2.27% |
| Camber Capital Management LP | 685,000 | $68,918,000 | 2.12% |
| LBJ Family Wealth Advisors, Ltd. | 30,359 | $3,054,000 | 1.82% |
| MADDEN SECURITIES Corp | 33,127 | $3,333,000 | 1.80% |
| Biondo Investment Advisors, LLC | 104,120 | $10,475,000 | 1.80% |
| Tolleson Wealth Management, Inc. | 60,750 | $6,112,000 | 1.73% |
| Keel Point, LLC | 97,074 | $9,767,000 | 1.26% |